vistusertib Report issue

Small molecule Experimental
AACT ChEMBL DrugBank PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1
  • InChIKey: JUSFANSTBFGBAF-IRXDYDNUSA-N
  • Mol. Mass: 462.55
  • ALogP: 2.5
  • ChEMBL Molecules:
    vistusertib  
    azd-2014  
More Chemistry

Pharmacology

Alternative names

azd2014 | azd 2014 | azd-2014 | vistusertib

Organizations (30)

Research & Development (30)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (28)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (28)


 

Adenocarcinoma (Phase 2)

BRCA1 Protein (Phase 1/Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Endometrial Neoplasms (Phase 1/Phase 2)

Fallopian Tube Neoplasms (Phase 1/Phase 2)

Glioblastoma (Phase 1/Phase 2)

Hamartoma (Phase 1/Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)

Lung Neoplasms (Phase 1/Phase 2)

Lymphoma (Phase 1/Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Large-Cell, Immunoblastic (Phase 1/Phase 2)

Meningioma (Phase 2)

Mutation (Phase 1/Phase 2)

Neoplasm Metastasis (Phase 1/Phase 2)

Neoplasms (Phase 2)

Neurofibromatosis 2 (Phase 2)

Ovarian Neoplasms (Phase 1/Phase 2)

Prostatic Neoplasms (Phase 1)

Prostatic Neoplasms, Castration-Resistant (Phase 1)

Small Cell Lung Carcinoma (Phase 2)

Stomach Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 1/Phase 2)

Urinary Bladder Neoplasms (Phase 1)

Uterine Neoplasms (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 34
  • # of Trial Organizations: 30

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue